Roche Holding AG

Roche Holding AG is a Swiss multinational healthcare company operating through two primary divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division develops innovative medicines across therapeutic areas including oncology, cardio-metabolic disorders, hemophilia, inflammatory and autoimmune conditions, neurological disorders, ophthalmology, respiratory diseases, and transplantation. The Diagnostics division manufactures diagnostic equipment and reagents for medical applications, including tests for cancer, diabetes, infectious diseases, and other conditions, along with digital health solutions. Roche operates globally across Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand, serving physicians, hospitals, clinics, and consumers. The company owns subsidiaries including Genentech, a leading biotechnology firm, and Chugai Pharmaceuticals. Roche maintains a strong commitment to research and development, continuously advancing science to improve health outcomes and ensure broad access to healthcare solutions worldwide. The company integrates its combined pharmaceutical and diagnostic strengths to enhance patient care and reduce healthcare system costs.